Hint mode is switched on Switch off

Seaport Therapeutics, ordinary share
SPTX, US81221K1088

Add a stock to WL
Choose all Reset all
Seaport Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Seaport Therapeutics Inc is a clinical-stage therapeutics company focused on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders.
  • Issuer
  • Full borrower / issuer name
    Seaport Therapeutics Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    SPTX
  • Placement
    01.05.2026
  • Lock up period
    180
  • Number of papers
    14,160,000
  • Volume of raised funds
    254.88 mln USD
  • Placement share
    26.7%
  • Final placement price
    18 USD
  • Price change since placement date
    18.28%
  • By capitalization
    954.5 mln USD

IFRS/US GAAP reports

2026
I q eng
II q eng

Related Stock indices

Indicators

News

03/08/2026 Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
08/06/2026 Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
08/06/2026 Seaport Therapeutics: Results Of Operations And Financial Condition, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.